OtherClinical Investigations
Gated 99mTc-Tetrofosmin SPECT for Discriminating Infarct from Artifact in Fixed Myocardial Perfusion Defects
Samuel Fleischmann, Pascal Koepfli, Mehdi Namdar, Christophe A. Wyss, Rolf Jenni and Philipp A. Kaufmann
Journal of Nuclear Medicine May 2004, 45 (5) 754-759;
Samuel Fleischmann
Pascal Koepfli
Mehdi Namdar
Christophe A. Wyss
Rolf Jenni
In this issue
Gated 99mTc-Tetrofosmin SPECT for Discriminating Infarct from Artifact in Fixed Myocardial Perfusion Defects
Samuel Fleischmann, Pascal Koepfli, Mehdi Namdar, Christophe A. Wyss, Rolf Jenni, Philipp A. Kaufmann
Journal of Nuclear Medicine May 2004, 45 (5) 754-759;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Semiconductor Detectors Allow Low-Dose-Low-Dose 1-Day SPECT Myocardial Perfusion Imaging
- Improved Outcome Prediction by SPECT Myocardial Perfusion Imaging After CT Attenuation Correction
- Long-term prognostic value of left ventricular dyssynchrony assessment by phase analysis from myocardial perfusion imaging
- Radiopharmaceutical Agents for Myocardial Perfusion Imaging
- Added Value of Coronary Artery Calcium Score as an Adjunct to Gated SPECT for the Evaluation of Coronary Artery Disease in an Intermediate-Risk Population
- Cardiac Image Fusion from Stand-Alone SPECT and CT: Clinical Experience